Invokana is a diabetes drug known as an SGLT2 inhibitor that blocks glucose (sugar) from being absorbed into the bloodstream.
Invokana is an oral medication prescribed to treat Type 2 diabetes. It contains the active ingredient canagliflozin. Invokamet and Invokamet XR are part of the Invokana family of medicines. They are combination drugs containing canagliflozin and metformin.

Invokana Lawsuits Overview

Associated Products:   Invokana (canagliflozin), Invokamet

Companies Involved: Janssen Pharmaceuticals (Johnson & Johnson)

Common Uses:   To improve blood sugar control in adults with type 2 diabetes

How Many Lawsuits:  1,100

Major Side Effects: Fournier’s Gangrene, Ketoacidosis, Kidney Injuries

Lawsuit Locations: District of  New Jersey & CA, NJ, PA

Side effects of INVOKANA

Risk of Lower-Limb Amputations Increases

Fournier’s Gangrene

Diabetic Ketoacidosis

Kidney Failure

Acute Pancreatitis

The FDA has issued several warnings for users of Invokana

September 2015

Safety announcement revising the label for Invokana to include a warning on the risk of bone fracture and decreased bone mineral density after studies showed an increased risk of bone fractures as early as 12 weeks after starting Invokana.

December 2015

Safety announcement ordering the addition of diabetic ketoacidosis warnings to all Invokana labels after a safety review of the medication showed a substantial risk of this medical condition.

May 2016

Safety announcement ordering the addition of first amputation warning based on interim analysis of CANVAS and CANVAS-R studies.

June 2016

Safety announcement requiring additional health warnings on Invokana labels as studies revealed a harmful risk of kidney injury and acute kidney failure.

May 2017

Safety announcement ordering the addition of second amputation warning, requiring a label update with a boxed warning.

August 2018

Safety announcement ordering the addition of warning about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes.

INVOKANA Verdicts and Settlements

Many individuals have filed Lawsuits against Johnson & Johnson, the manufacturer of Invokana, claiming the company failed to warn patients of extreme side effects like a higher risk of lower limb amputation, Fournier’s gangrene, diabetic ketoacidosis and kidney failure.


  • Johnson & Johnson has faced more than 1,150 Invokana lawsuits.
  • Federal Invokana Lawsuits (MDL 2750) Most Invokana lawsuits have been organized into multidistrict litigation (MDL) in the U.S. District Court of New Jersey under the designation MDL 2750 (IN RE: Invokana (Canagliflozin) Products Liability Litigation).
  • State Invokana Lawsuits Some plaintiffs might have a better chance at receiving compensation from state courts, depending on the state’s laws and other factors. Pennsylvania has seen more Invokana lawsuits filed than any other state, although there are quite a few lawsuits filed in New Jersey and California as well.

Verdicts and Settlements

In October 2018, Janssen Pharmaceuticals file a motion to settle many of the 1,100 Invokana lawsuits against the company. According to a motion to establish a qualified settlement fund filed on October 16, 2018, the Invokana settlement amount is confidential. Complete details of the settlement are still being negotiated as of December 2018.


Compensation may be awarded to cover the medical expenses, travel to and from healthcare appointments, lost wages, pain, suffering or future medical care loss of income, diminished enjoyment of life, as well as the need for lifelong medical treatment, permanent disability, loss of companionship and funeral expenses.
In some cases, punitive damages may also be awarded to punish the Defendants for promoting a dangerous drug.
An Invokana Attorney can help you understand what compensation may be available to you based on your circumstances. If you or your loved one has suffered due to prescribed usage of Invokana and is considering filing a law suit, contact an Invokana Attorney for a FREE case evaluation. 

Are you a victim?

Speak with one of our representatives today!